Hans Olov Sjögren (Former)
1 – 15 of 58
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis
(
- Contribution to journal › Article
- 2018
-
Mark
Tumor Regression and Cure Depends on Sustained Th1 Responses
(
- Contribution to journal › Article
- 2017
-
Mark
T Cell Activation Pathways : B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
(
- Contribution to journal › Article
- 2016
-
Mark
Maintenance of the E.coli dcm Methylation of the CMV Promoter, in Contrast to Hypomethylation of the Recognition Sequence of Transcription Factor NFkB in Transfected GBM Cells
(
- Contribution to journal › Article
- 2014
-
Mark
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(9). p.3538-3543(
- Contribution to journal › Article
- 2010
-
Mark
Toxicity-Reducing Potential of Extracorporeal Affinity Adsorption Treatment in Combination With the Auristatin-Conjugated Monoclonal Antibody BR96 in a Syngeneic Rat Tumor Model
(
- Contribution to journal › Article
- 2009
-
Mark
Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existence.
(
- Contribution to journal › Article
- 2008
-
Mark
High dose radioimmunotherapy combined with extracorporeal depletion in syngeneic rat tumor model. Evaluation of toxicity, therapeutic effect, and tumor model
2008) Twelfth Conference on Cancer Therapy with Antibodies and Immunoconjugates In Cancer Biotherapy and Radiopharmaceuticals 23(4). p.517-517(
- Contribution to journal › Published meeting abstract
-
Mark
Evaluation of toxicity-reducing potential of ECAT in combination with drug-conjugated mAb BR96
2008) Twelfth Conference on Cancer Therapy with Antibodies and Immunoconjugates In Cancer Biotherapy and Radiopharmaceuticals 23(4). p.520-520(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
(
- Contribution to journal › Article
-
Mark
A nonsurgical technique for blood access in extracorporeal affinity adsorption of antibodies in rats.
(
- Contribution to journal › Article
-
Mark
Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion.
(
- Contribution to journal › Article
- 2006
-
Mark
Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma
(
- Contribution to journal › Article
- 2005
-
Mark
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
(
- Contribution to journal › Article
-
Mark
Culturing of human tumor cells for use in immune gene tumor therapy
2005) World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology In Neuro-Oncology 7(3). p.371-371(
- Contribution to journal › Published meeting abstract